The Vertical Group
Venture capitalBerkeley Heights · Pre-Seed–Series B · 3 people tracked
Investment thesis
The Vertical Group invests in medical technology and biotechnology companies, typically at early stages. Its principals bring more than 40 years of experience as founders, early-stage investors, major shareholders, and executives across many successful medical technology companies. The firm emphasizes deep operating and investing expertise in the medical device and life sciences fields, and its principals are active in the National Venture Capital Association, having helped found the Association's Medical Industry Group.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website & public directories
What they invest in
from 16 of 24 portfolio companiesHealthtech ×11Biotech ×5Medical Devices ×4Hardware ×3Digital Health ×2Media & Entertainment ×2Advanced Manufacturing ×1Consumer ×1
HQs:United States×12
Investments · 24 tracked
founders shown can be your intro pathBy year:2024 · 12021 · 22015 · 42012 · 18 dated
Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.
Digital HealthHealthtechWellness & FitnessSan Francisco, US
Andrew DiMichelle(Executive Officer, Director)Adrian James(Executive Officer, Director)Sean Duffy(Executive Officer, Director)Wei-Li Shaoin
BoardJonathan Root(Director)inCasper De Clercq(Director)in
Co-investorsAndreessen HorowitzBlackbird GiantsCanvas VenturesCivilization Ventures Management, LlcDesigner FundFounder Collective+12 more
Outset Medical develops dialysis technology aimed at driving broader adoption and lowering the cost of care for patients and healthcare providers.
Enterprise SoftwareHardwareHealthtechMedical DevicesSan Jose, US
Nabeel Ahmed(Executive Officer)Marc Nash(Executive Officer)John Brottem(General Counsel)Leslie Trigg(Chair and CEO)Jeff Mack(Executive Officer)Renee Gaeta(Chief Financial Officer)
Co-investorsDurable Capital PartnersFidelity Investments
HealthtechSan Mateo, US
BoardTony Chou(Executive Officer, Director)inJack Lasersohn(Director)inJonathan Root(Director)
Board seatJack W. Lasersohn· per SEC Form D · $319.8K raise · filed Dec 2021
HealthtechSan Mateo, US
BoardJonathan Root(Director)Jack Lasersohn(Director)inTony Chou(Executive Officer, Director)in
Board seatJack W. Lasersohn· per SEC Form D · $639.6K raise · filed Dec 2021
Route 92 Medical develops neurointervention catheter systems and devices aimed at improving outcomes for neurovascular patients, including stroke treatment.
BiotechHardwareHealthtechMedical DevicesSan Mateo, US
Dr. Chou(Founder & Chief Executive Officer)Cindy Lynch(Executive Officer)Tony Chou(Executive Officer, Director)in
BoardJack Lasersohn(Director)inTamir Meiri(Director)Jonathan Root(Director)in
Board seatJack W. Lasersohn· per SEC Form D · $50M raise · filed Apr 2026
Co-investorsNorwest Venture PartnersRunway Growth CapitalUS Venture PartnersSofinnova Ventures
HealthtechSunnyvale, US
Erica Rogers(Executive Officer, Director)
BoardJack Lasersohn(Director)inNoah Knauf(Director)Elizabeth Weatherman(Director)Richard Mott(Director)
Board seatJack W. LasersohnTony Chou· per SEC Form D
Co-investorsB Capital Group
CustomDyn provides design, engineering, and fabrication services across multiple materials including steel, aluminum, wood, and plastics.
Advanced ManufacturingHardware
Co-investorsLatterell Venture Partners
MM+M (Medical Marketing and Media) is a trade media outlet covering the healthcare marketing and advertising industry, publishing rankings and profiles such as its annual Agency Network Family Tree and lists of top healthcare agencies.
Marketing TechMedia & Entertainment
Co-investorsRed River West
Monteris develops minimally invasive laser ablation technology (LITT) used to treat brain conditions including oncology tumors and drug-resistant epilepsy.
BiotechHealthtechMedical DevicesPlymouth, US
JAMES ERICKSON(Executive Officer)MARTIN EMERSON(Executive Officer, Director)John Schellhorn(Executive Officer, Director, Promoter)Robert K Davidson(Executive Officer)Gregory Barrett(Director)Gary Bantle(Director)
Co-investorsVensana Capital
Co-investorsSlow Ventures
Mereo BioPharma is a rare disease drug developer that funds and advances novel therapeutic candidates not progressed by their originating pharmaceutical or biotech companies, with lead programs in osteogenesis imperfecta and Alpha-1 Antitrypsin Deficiency-associated Lung Disease.
BiotechHealthtech
Co-investorsLatterell Venture Partners
Co-investorsLatterell Venture Partners
Co-investorsLatterell Venture Partners
Remedy Pharmaceuticals is a pharmaceutical company developing Cirara, an investigational drug studied in clinical trials for patients who have suffered a stroke.
BiotechHealthtechNew York, US
SVEN JACOBSON(Executive Officer, Director)
BoardDAVID GELIEBTER(Director)DAVID M. GELIEBTER(Director)
Co-investorsBroadview Ventures
StartUp Health operates a private global membership community for health innovators — including founders, healthcare executives, investors, and clinicians — offering a member network app, live AMAs and fireside chats, in-person event access, and a content library.
Digital HealthHealthtechNew York, US
Steven Krein(Strategic Advisor & Co-founder)inUnity Stoakes(CEO, President & Co-founder)inBari Krein(CSO, Managing Partner)inRob Belsky(CFO)in
BoardWayne Kimmel(Director)Jerry Levin(Director)
Co-investorsKaiser Permanente VenturesTrue Ventures
HealthtechLexington, US
Simon Williams(Executive Officer, Director)John Hartnett(Executive Officer)
BoardRichard B. Emmitt(Director)Edward M. Giles(Director)Anthony J. Sinskey(Director)
Co-investorsNovartis Venture Fund
BiotechSan Diego, US
Brittany Bradrick(Executive Officer)Anne Sandan(Executive Officer)Elizabeth Bui(Executive Officer)Steve White(Executive Officer)Howard Foyt(Executive Officer)Donald J. Elmer(Director)
Co-investorsBain Capital Life SciencesRA CapitalSanderling VenturesRed Tree Venture
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 3
IPOs and acquisitions across the tracked portfolioOmada HealthNASDAQ: OMDAOutset MedicalNASDAQ: OMOncoMed Websiteacq. by Mereo BioPharma
Portfolio news
latest coverage across their companiesOmada Health · ca.investing.com · Jul 17, 2026
Outset Medical · stocktitan.net · Jun 29, 2026
Monteris Medical · winnipegfreepress.com · Mar 19, 2026
Frequently asked questions
- How many investments has The Vertical Group made?
- The Vertical Group has 22 tracked investments, 1 of which have exited via acquisition or IPO.
- What stage does The Vertical Group invest at?
- The Vertical Group invests at the Pre-Seed, Seed, Series A, Series B stages.
- What is The Vertical Group's typical check size?
- The Vertical Group typically writes checks of $250K – $5M.
- What sectors does The Vertical Group focus on?
- The Vertical Group focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is The Vertical Group located?
- The Vertical Group is headquartered in Berkeley Heights, US.
- Who does The Vertical Group co-invest with?
- The Vertical Group most often shares deals with Latterell Venture Partners, Canvas Ventures, Kaiser Permanente Ventures, among 52 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
Panacea Venture is a global investment firm, spun out from Kleiner Perkins, focused on life sciences and healthcare innovation. It invests across geographies and stages, from company formation through expansion and public markets.
Lang Sheng Investment (朗盛投资) is a leading Chinese investment firm focused on the large healthcare sector, with experience in screening, investing in, and supporting medical and health companies.